Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 418
of 21Next
1:

Police and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facility.

DeBeck K, Wood E, Zhang R, Tyndall M, Montaner J, Kerr T.

Subst Abuse Treat Prev Policy. 2008 May 7;3:11.

PMID: 18462491 [PubMed - indexed for MEDLINE]

2:

Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.

Wood RA, Wood E, Lai C, Tyndall MW, Montaner JS, Kerr T.

Int J Drug Policy. 2008 Jun;19(3):183-8. Epub 2008 Mar 26.

PMID: 18367389 [PubMed - indexed for MEDLINE]

3:

Factors associated with public injecting among users of Vancouver's supervised injection facility.

McKnight I, Maas B, Wood E, Tyndall MW, Small W, Lai C, Montaner JS, Kerr T.

Am J Drug Alcohol Abuse. 2007;33(2):319-25.

PMID: 17497555 [PubMed - indexed for MEDLINE]

4:

Effects of police confiscation of illicit drugs and syringes among injection drug users in Vancouver.

Werb D, Wood E, Small W, Strathdee S, Li K, Montaner J, Kerr T.

Int J Drug Policy. 2008 Aug;19(4):332-8. Epub 2007 Sep 27.

PMID: 17900888 [PubMed - indexed for MEDLINE]

5:

A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.

Kerr T, Small W, Moore D, Wood E.

Int J Drug Policy. 2007 Jan;18(1):37-45. Epub 2007 Jan 16.

PMID: 17689342 [PubMed - indexed for MEDLINE]

6:

Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.

Milloy MJ, Kerr T, Mathias R, Zhang R, Montaner JS, Tyndall M, Wood E.

Am J Drug Alcohol Abuse. 2008;34(4):499-509.

PMID: 18584579 [PubMed - indexed for MEDLINE]

7:

Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.

Petrar S, Kerr T, Tyndall MW, Zhang R, Montaner JS, Wood E.

Addict Behav. 2007 May;32(5):1088-93. Epub 2006 Aug 22.

PMID: 16930849 [PubMed - indexed for MEDLINE]

8:

The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.

Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW, Hogg RS, O'Shaughnessy MV, Schechter MT.

J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):2-8.

PMID: 12514408 [PubMed - indexed for MEDLINE]

9:

Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside.

Kerr T, Wood E, Small D, Palepu A, Tyndall MW.

CMAJ. 2003 Oct 14;169(8):759-63.

PMID: 14557313 [PubMed - indexed for MEDLINE]

10:

Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility.

Wood E, Kerr T, Stoltz J, Qui Z, Zhang R, Montaner JS, Tyndall MW.

Public Health. 2005 Dec;119(12):1111-5. Epub 2005 Oct 7.

PMID: 16214189 [PubMed - indexed for MEDLINE]

11:

Public injecting among a cohort of injecting drug users in Vancouver, Canada.

DeBeck K, Small W, Wood E, Li K, Montaner J, Kerr T.

J Epidemiol Community Health. 2009 Jan;63(1):81-6. Epub 2008 Jul 15.

PMID: 18628270 [PubMed - in process]

13:

Employment among users of a medically supervised safer injection facility.

Richardson L, Wood E, Zhang R, Montaner J, Tyndall M, Kerr T.

Am J Drug Alcohol Abuse. 2008;34(5):519-25.

PMID: 18821450 [PubMed - indexed for MEDLINE]

14:

Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study.

Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T.

BMC Public Health. 2008 Dec 9;8(1):405. [Epub ahead of print]

PMID: 19068133 [PubMed - as supplied by publisher]

15:

Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver.

Kerr T, Marsh D, Li K, Montaner J, Wood E.

Drug Alcohol Depend. 2005 Dec 12;80(3):329-35. Epub 2005 Jun 17.

PMID: 15964714 [PubMed - indexed for MEDLINE]

16:

Rate of detoxification service use and its impact among a cohort of supervised injecting facility users.

Wood E, Tyndall MW, Zhang R, Montaner JS, Kerr T.

Addiction. 2007 Jun;102(6):916-9.

PMID: 17523986 [PubMed - indexed for MEDLINE]

18:

Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.

Tyndall MW, Kerr T, Zhang R, King E, Montaner JG, Wood E.

Drug Alcohol Depend. 2006 Jul 27;83(3):193-8. Epub 2005 Dec 13.

PMID: 16356659 [PubMed - indexed for MEDLINE]

19:

My place, your place, or a safer place: the intention among Montréal injecting drug users to use supervised injecting facilities.

Green TC, Hankins CA, Palmer D, Boivin JF, Platt R.

Can J Public Health. 2004 Mar-Apr;95(2):110-4.

PMID: 15074900 [PubMed - indexed for MEDLINE]

20:

Condom use among injection drug users accessing a supervised injecting facility.

Marshall BD, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T.

Sex Transm Infect. 2008 Sep 23. [Epub ahead of print]

PMID: 18812391 [PubMed - as supplied by publisher]

Items 1 - 20 of 418
of 21Next